BioCentury | Oct 22, 2007
Company News

Allergan, Esprit, Orthovita deal

...VITA also will acquire raw material and equipment related to the production of the company's Vitagel...
...procedures as an adjunct to hemostasis. AGN will receive $6.6 million. VITA has rights to Vitagel...
BioCentury | Dec 11, 2006
Company News

Angiotech, Orthovita deal

...$9 million to eliminate the royalties it owes under a 204 deal to market ANP's Vitagel...
...2017, and eliminates certain termination rights and eliminates VITA's obligation to meet minimal sales requirements. Vitagel...
BioCentury | Jun 26, 2006
Clinical News

Vitagel regulatory update

...Vitagel surgical hemostat. The new approval permits Orthovita to sell Vitagel. Orthovita has been distributing Vitagel...
...ineffective. Angiotech Pharmaceuticals Inc. (TSX:ANP; ANPI), Vancouver, B.C. Orthovita Inc. (VITA; EASD:VITA), Malvern, Penn. Product: Vitagel...
BioCentury | Jun 28, 2004
Company News

Angiotech, Orthovita sales and marketing update

...VITA received North American rights to sell and distribute ANP's Costasis surgical hemostat for use in...
...hemostat for use in spine and orthopedic surgery. The companies plan to rename the compound Vitagel...
BioCentury | Oct 7, 2002
Finance

Pummeling the microcaps

...its device-coating technology with CSON's biomaterials, which include the marketed products CoSeal surgical sealant and CoStasis...
BioCentury | Oct 7, 2002
Company News

Angiotech, Cohesion Technologies deal

...therapeutics, such as paclitaxel-coated stents, with CSON's biomaterials. CSON markets its CoSeal surgical sealant and CoStasis...
BioCentury | Sep 30, 2002
Company News

Angiotech acquiring Cohesion

...therapeutics, such as paclitaxel-coated stents, with CSON's biomaterials. CSON markets its CoSeal surgical sealant and CoStasis...
BioCentury | Mar 25, 2002
Clinical News

CoStasis surgical hemostat regulatory update

...The FDA approved an expanded label for CoStasis to include stopping or controlling active bleeding during...
...procedures except neurological, ophthalmic and urological surgeries. Cohesion Technologies Inc. (CSON), Palo Alto, Calif. Product: CoStasis...
BioCentury | Nov 19, 2001
Company News

Cohesion Technologies biomaterial/skin/wound news

...resulting in expected annual savings of $1.5 million, and will focus its resources on its CoStasis...
BioCentury | Jul 3, 2000
Clinical News

CoStasis and DynaStat surgical hemostats regulatory update

...The FDA granted marketing clearance for CSON's CoStasis surgical hemostat used to stop or control active...
...marketing partner U.S. Surgical Corp. (Norwalk, Conn.). Cohesion Technologies Inc. (CSON), Palo Alto, Calif. Product: CoStasis...
Items per page:
1 - 10 of 17